Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8158213rdf:typepubmed:Citationlld:pubmed
pubmed-article:8158213lifeskim:mentionsumls-concept:C0079259lld:lifeskim
pubmed-article:8158213lifeskim:mentionsumls-concept:C0917713lld:lifeskim
pubmed-article:8158213lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:8158213lifeskim:mentionsumls-concept:C0205161lld:lifeskim
pubmed-article:8158213lifeskim:mentionsumls-concept:C0456389lld:lifeskim
pubmed-article:8158213lifeskim:mentionsumls-concept:C0547044lld:lifeskim
pubmed-article:8158213lifeskim:mentionsumls-concept:C0449822lld:lifeskim
pubmed-article:8158213lifeskim:mentionsumls-concept:C0332183lld:lifeskim
pubmed-article:8158213pubmed:issue2lld:pubmed
pubmed-article:8158213pubmed:dateCreated1994-5-16lld:pubmed
pubmed-article:8158213pubmed:abstractTextDystrophin is a muscle cytoskeletal protein with a molecular mass (MM) of approximately 420 kDa and an isoelectric point (pI) of approximately 5.5, which is abnormal in size and/or abundance in Becker muscular dystrophy (BMD). We investigated the abnormality of dystrophin molecule in muscles biopsied from 23 BMD patients using the two-dimensional gel electrophoresis (TDGE). We found 7 protein spots which reacted specifically with the monoclonal anti-dystrophin antibody (mAb) A1C raised against N-terminal domain of the normal dystrophin. These spots were focused on the two-dimensional gel at the same position as the normal dystrophin (#1), at the position with MM approximately 480 kDa/pI approximately 5.35 (#2), the position with MM approximately 400-330 kDa/pI approximately 5.51-5.47 (#3), the position with MM approximately 300 kDa/pI approximately 5.4 (#4), the position with MM approximately 235-250 kDa/pI approximately 5.53-5.5 (#5), the position with MM approximately 165 kDa/pI approximately 6.0 (#6), and the position with MM approximately 160 kDa/pI approximately 5.75 (#7). These spots were classified into five patterns in individuals, that is, #1 alone in 3 patients, #3 alone in 1, the combination of #3 and 5 in 17, the combination of #1, 3 and 5 in 1 and the combination of #1, 2, 4, 6 and 7 in 1. The combination of #3 and 5 was observed in 17 of 23 patients (75%).(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8158213pubmed:languageenglld:pubmed
pubmed-article:8158213pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8158213pubmed:citationSubsetIMlld:pubmed
pubmed-article:8158213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8158213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8158213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8158213pubmed:statusMEDLINElld:pubmed
pubmed-article:8158213pubmed:monthFeblld:pubmed
pubmed-article:8158213pubmed:issn0022-510Xlld:pubmed
pubmed-article:8158213pubmed:authorpubmed-author:ShimizuTTlld:pubmed
pubmed-article:8158213pubmed:authorpubmed-author:MiyamotoKKlld:pubmed
pubmed-article:8158213pubmed:authorpubmed-author:HoriSSlld:pubmed
pubmed-article:8158213pubmed:authorpubmed-author:OhtaniSSlld:pubmed
pubmed-article:8158213pubmed:authorpubmed-author:TanabeHHlld:pubmed
pubmed-article:8158213pubmed:authorpubmed-author:NonakaIIlld:pubmed
pubmed-article:8158213pubmed:authorpubmed-author:SahashiKKlld:pubmed
pubmed-article:8158213pubmed:authorpubmed-author:IbiTTlld:pubmed
pubmed-article:8158213pubmed:issnTypePrintlld:pubmed
pubmed-article:8158213pubmed:volume121lld:pubmed
pubmed-article:8158213pubmed:ownerNLMlld:pubmed
pubmed-article:8158213pubmed:authorsCompleteYlld:pubmed
pubmed-article:8158213pubmed:pagination183-9lld:pubmed
pubmed-article:8158213pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:meshHeadingpubmed-meshheading:8158213-...lld:pubmed
pubmed-article:8158213pubmed:year1994lld:pubmed
pubmed-article:8158213pubmed:articleTitleMultiplicity of abnormal dystrophin in Becker muscular dystrophy. A Becker muscular dystrophy gene frequently produced two smaller sizes of dystrophin.lld:pubmed
pubmed-article:8158213pubmed:affiliationDepartment of Molecular and Cellular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Japan.lld:pubmed
pubmed-article:8158213pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8158213pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed